- Home
- /
- Drugs
- /
- I
- /
- Indomethacin
- /
- Indomethacin INDOMETHACIN 75 mg/1 Zydus Lifesciences Limited
Indomethacin
- Indomethacin INDOMETHACIN 75 mg/1 Asclemed USA, Inc.
- Indomethacin INDOMETHACIN 75 mg/1 Zydus Pharmaceuticals USA Inc.
- Indomethacin INDOMETHACIN 75 mg/1 Northwind Pharmaceuticals, LLC
- Indomethacin INDOMETHACIN 75 mg/1 Bryant Ranch Prepack
- Indomethacin INDOMETHACIN 75 mg/1 REMEDYREPACK INC.
- Indomethacin INDOMETHACIN 75 mg/1 American Health Packaging
- Indomethacin ER INDOMETHACIN 75 mg/1 Advanced Rx Pharmacy of Tennessee, LLC
- INDOMETHACIN INDOMETHACIN 75 mg/1 Bryant Ranch Prepack
- Indomethacin INDOMETHACIN 75 mg/1 Bryant Ranch Prepack
- INDOMETHACIN INDOMETHACIN 75 mg/1 PD-Rx Pharmaceuticals, Inc.
- Indomethacin INDOMETHACIN 75 mg/1 Bryant Ranch Prepack
- Indomethacin INDOMETHACIN 75 mg/1 Zydus Lifesciences Limited
- INDOMETHACIN INDOMETHACIN 75 mg/1 Bryant Ranch Prepack
- Indomethacin INDOMETHACIN 75 mg/1 REMEDYREPACK INC.
- Indomethacin INDOMETHACIN 75 mg/1 Proficient Rx LP
- Indomethacin INDOMETHACIN 75 mg/1 REMEDYREPACK INC.
Summary of product characteristics
Effective Time
20230926
Version
5
Spl Product Data Elements
indomethacin indomethacin INDOMETHACIN INDOMETHACIN STARCH, CORN FD&C BLUE NO. 1 HYPROMELLOSES LACTOSE MONOHYDRATE CELLULOSE, MICROCRYSTALLINE SODIUM LAURYL SULFATE TALC TITANIUM DIOXIDE GELATIN SHELLAC PROPYLENE GLYCOL AMMONIA FERROSOFERRIC OXIDE POTASSIUM HYDROXIDE WATER DARK BLUE DARK BLUE CAPSULE ZA;79;75mg
Application Number
ANDA202711
Brand Name
Indomethacin
Generic Name
indomethacin
Product Ndc
70771-1203
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1203-6 Indomethacin Extended-release Capsules, 75 mg 60 Capsules Rx only label
Spl Medguide
SPL MEDGUIDE
Drug section
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.